1- or 3-Month DAPT in Patients With HBR With or Without Oral Anticoagulant Therapy After PCI.
HBR患者在PCI後是否需要口服抗凝劑治療,1個月或3個月的雙抗血小板治療。
JACC Cardiovasc Interv 2023-10-27
Treatment strategies of the thromboembolic risk in kidney failure patients with atrial fibrillation.
腎衰竭患者合併心房顫動的血栓栓塞風險治療策略。
Nephrol Dial Transplant 2024-05-30
Continuation vs Discontinuation of Renin-Angiotensin System Inhibitors Before Major Noncardiac Surgery: The Stop-or-Not Randomized Clinical Trial.
在重大非心臟手術前持續使用與停止使用腎素-血管緊張素系統抑制劑:Stop-or-Not 隨機臨床試驗。
JAMA 2024-08-30
De-escalation to ticagrelor monotherapy versus 12 months of dual antiplatelet therapy in patients with and without acute coronary syndromes: a systematic review and individual patient-level meta-analysis of randomised trials.
急性冠狀動脈綜合症患者與非患者中,降級至 ticagrelor 單藥治療與 12 個月雙重抗血小板治療的比較:隨機試驗的系統性回顧及個別患者層級的 meta 分析。
Lancet 2024-09-03